UK signs 'landmark' deals for antiviral Covid treatments

Video Credit: ODN
Published on October 20, 2021 - Duration: 00:53s

UK signs 'landmark' deals for antiviral Covid treatments

The UK has agreed two "landmark" deals with pharmaceutical companies Pfizer and Merck Sharp and Dohme (MSD) to secure "hundreds of thousands" of doses of new Covid treatments.

Health Secretary Sajid Javid said: "These antivirals have the potential to speed up recovery time and to stop infections from progressing … we'll keep working to secure even more of these incredible treatments." Report by Buseld.

Like us on Facebook at http://www.facebook.com/itn and follow us on Twitter at http://twitter.com/itn


You are here


💡 newsR Knowledge: Other News Mentions

Pfizer

American multinational pharmaceutical corporation
The emergence of the Omicron strain could lead drug companies scrambling to the drawing board to tweak their Covid-19 vaccine plans. US firm Novavax and..
Credit: IndiaTimes - Published 5 hours ago

Vaccine manufacturers have expressed confidence that they will be able to rapidly adapt their jabs if the Omicron variant spreads.
3 days ago • Sky News
The European Union drugs regulator has authorised Pfizer’s coronavirus vaccine for use on children aged from five to 11.
5 days ago • Sky News

COVID-19

Contagious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
As many people who lost their dear ones to Covid-19 have not filed an application for compensation, the Supreme Court on Monday said that online portals should..
Credit: IndiaTimes - Published 6 hours ago

Expressing support for Africa, which has been rattled by the discovery of Covid-19 variant Omicron, the government on Monday announced it had cleared all orders..
Credit: IndiaTimes - Published 7 hours ago

With the emergence of the Omicron variant, public health experts want laboratories to conduct RT-PCR tests in whole for all the three genes, particularly on..
Credit: IndiaTimes - Published 7 hours ago

Amid mounting fear over the new SARS-COV2 variant Omicron, an expert committee on Covid immunisation is considering to recommend an “additional dose” to..
Credit: IndiaTimes - Published 8 hours ago




You might like